NKGen Biotech, Inc. (NASDAQ:NKGNW) Short Interest Up 1,193.3% in October

NKGen Biotech, Inc. (NASDAQ:NKGNW) was the recipient of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 19,400 shares, a growth of 1,193.3% from the October 15th total of 1,500 shares. Based on an average daily volume of 8,000 shares, the short-interest ratio is currently 2.4 days.

NKGen Biotech Trading Up 283.3 %

NKGNW stock traded up $0.06 during trading on Wednesday, reaching $0.09. The company’s stock had a trading volume of 5,402 shares, compared to its average volume of 16,826. The company’s fifty day moving average is $0.05 and its 200-day moving average is $0.08. NKGen Biotech has a 1 year low of $0.02 and a 1 year high of $0.29.

About NKGen Biotech

NKGen Biotech, Inc operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials.